Back in February, half-year results from infection control group Tristel (TSTL) were a little disappointing, causing the bears to sink their teeth in. But last week's full-year trading update has gone a long way towards silencing the doubters. Turnover and pre-tax profits are both ahead of expectations and at £17m and £3.1m respectively (£15.3m and £2.6m in FY2015), significantly up on last year.
IC TIP:
Buy
at
133p
Cash generation is still flying, providing a cash balance of £5.7m, with no debt on the balance sheet. This has given the opportunity for another special dividend of 3p a share, following the 2p paid last August.
